Search Results

Lab-grown clusters of human brain cells integrate so well into young rats’ brains they enable researchers to study neurodevelopmental disorders’ molecular and circuit underpinnings.

In the five decades since the emergence of recombinant DNA technology, researchers at Stanford Medicine have benefited from the close involvement of bioethics experts.

Biosciences PhD students began their careers at Stanford School of Medicine with crisp new lab coats, advice on graduate school success and warm words about the value of discovery.

Researchers have shown initial viability of an embryo that contains both chimpanzee and macaque cells in a preliminary study that explores the feasibility of primate organ genesis.

Stanford Medicine researchers have created a molecule that blocks an enzyme thought to be instrumental in causing colon cancer relapse or chemotherapy resistance.

Beginning July 2023, Wu will lead the nation’s largest nonprofit organization dedicated to advancing cardiovascular health.

Using a method they developed for stem cell transplants, a Stanford team has enabled children with immune disorders to receive a new immune system and a matching kidney from a parent.

Researchers found that damage to the brain’s white matter after COVID-19 resembles that seen after cancer chemotherapy, raising hope for treatments to help both conditions.

A brain mechanism needed for learning explains why epileptic seizures become more frequent, but a finding in rodents offers hope for treatment, according to a new study.

Strober, a professor and former chief of immunology and rheumatology, found a way for transplant recipients to reduce or abandon immunosuppressive drugs yet avoid organ rejection.